Translational research
Invitae is committed to providing genetic information to billions of people. In order to accelerate progress and achieve our mission, our advanced research teams focus on translational research projects. We want to move scientific discoveries into clinical practice to make a difference in the patients we support.
- Samadder NJ, et al. Comparison of universal genetic testing vs guideline-directed targeted testing for patients with hereditary cancer syndrome. JAMA Oncol. Published online October 30, 2020. doi.org/10.1001/jamaoncol.2020.6252
Uson PLS, et al. Germline cancer susceptibility gene testing in unselected patients with colorectal adenocarcinoma: A multi-center prospective study. Clinical Gastroenterology & Hepatology. Published online April 12, 2021. S1542-3565(21)00447-X. doi.org/10.1016/j.cgh.2021.04.013
Uson PLS, et al. Clinical impact of pathogenic germline variants in pancreatic cancer: Results From a multicenter, prospective, universal genetic testing study. Clin Transl Gastroenterol. Published online October 8, 2021. 12(10):e00414. doi: 10.14309/ctg.0000000000000414
Uson PLS, et al. Germline cancer susceptibility gene testing in unselected patients with colorectal adenocarcinoma: A multi-center prospective study.Cancer Prevention Research. Published online April 12, 2021. S1542-3565(21)00447-X. doi.org/10.1016/j.cgh.2021.04.013